Beta Bionics, Inc. · NASDAQ:BBNX

Hopman Mark sold 35,994 Beta Bionics, Inc. shares (Form 4/A)

Traded Sep 9, 2026 · Filed Sep 18, 2026

On Sep 9, 2026, Hopman Mark (Chief Commercial Officer) sold 35,994 Beta Bionics, Inc. shares at US$18.46 for US$664K under a trading plan, leaving 88,033 shares. Filed Sep 18, 2026 (Form 4/A).

Sold: 35,994 shares
Price: US$18.46
Value: US$664K
Holding after: 88,033 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Commercial Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 9, 2026	Common Stock	Sale	35,994	US$18.46	88,033	Direct

Source

View original at SEC

Related